Stryker falls short of Q4 sales amid electives pullback, robotics a bright spot

Despite a global slowdown in elective procedures, Stryker increased fourth-quarter sales by 3.2% to about $4.3 billion, though it fell short of Wall Street estimates. The quarter is slightly down from third-quarter results, which executives attributed to the procedure drop off, but the quarter was a significant improvement over the 24.3% sales decline taken in the second quarter.